Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations. We help you understand fair value estimates and potential upside or downside scenarios for any stock.
As of April 13, 2026, Crinetics Pharmaceuticals Inc. (CRNX) trades at a current price of $38.67, marking a 1.95% downward move in recent trading. This analysis outlines key market context, technical support and resistance levels, and potential near-term price scenarios for the biotech stock, with no recent earnings data available for the company at the time of writing. Recent price action for CRNX has been range-bound for much of this month, leading investors and traders to monitor key technical
Is Crinetics (CRNX) Stock Breaking Resistance | Price at $38.67, Down 1.95% - Reversal Setup
CRNX - Stock Analysis
3197 Comments
1617 Likes
1
Issael
Loyal User
2 hours ago
I read this like I was being tested.
👍 160
Reply
2
Ansell
Experienced Member
5 hours ago
Every step reflects careful thought.
👍 248
Reply
3
Cohyn
Power User
1 day ago
US stock competitive benchmarking and market share trend analysis to understand relative company performance. Our competitive analysis helps you identify which companies are winning or losing market share in their industries.
👍 17
Reply
4
Aime
Power User
1 day ago
This skill set is incredible.
👍 41
Reply
5
Sanvitha
Daily Reader
2 days ago
Anyone else just realized this?
👍 75
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.